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Background
We report the results of a Phase II clinical trial of
VRX496, an HIV-based vector encoding a 937-nt long
antisense (AS) RNA targeting the gp120 coding region
of HIV-1 env gene [1-3].
Materials and methods
Autologous CD4+ T lymphocytes from HIV-infected
subjects were genetically modified ex vivo with the vec-
tor, expanded, and 10-80 billion vector-modified cells
were reinfused into patients. Longitudinal effects of the
therapy on HIV-1 env evolution were analyzed in 17
subjects sampled both pre-infusion and monthly post-
infusion for 6 to 12 months. Plasma-derived viral RNA
from 144 samples was amplified, cloned, and the full-
length gp120 coding region was sequenced in 8-10
clones for each sample.
Results
Two AS-related factors: (a) sequence similarity of the AS
RNA with the targeted HIV transcripts at baseline, and
(b) persistence of the infused vector-modified cells during
the follow-up period, independently and cooperatively
influenced the following parameters: (i) pairwise genetic
distances of the gp120 conserved region sequences in the
post-infusion samples to the corresponding pre-infusion
samples, (ii) change in viral diversity from baseline, (iii)
genetic distances of the post-infusion viral quasispecies
to the most recent common ancestral sequence (MRCA)
of all patient’s viral sequences, relative to the MRCA dis-
tances of pre-infusion viruses, and (iv) change of HIV-1
plasma RNA load from baseline (P < 0.005 for all para-
meters). The effects of AS vector on virus evolution were
stronger for the AS-targeted region of gp120 than for the
untargeted region. The degree of virus evolution from
the pre-infusion to the post-infusion quasispecies (rela-
tive MRCA distances) negatively correlated with virus
replicative fitness, assessed ex vivo by growth competition
assay.
Conclusions
The same AS-related factors were associated with accel-
erated virus evolution and with the relative decrease in
plasma viral load, suggesting that selective pressure
exerted by the AS causes directional virus evolution,
presumably towards escape, which is associated with the
fitness loss.
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